Survival of Patients With Primary Cutaneous Melanoma and the Surgical Treatment Option Based on the Level of the Surface Protein PD-L1 in the Tumor Tissue

Background: The PD-­L1 level is mainly used to predict the effect of drug treatment in patients with melanoma. Despite the radical nature of surgery in these patients, the rate of disease progression remains high. Therefore, it is important to study the relation between the PD-­L1 level in the tumor...

詳細記述

書誌詳細

主要な著者:	S. S. Yargunin, I. V. Reshetov, Ya. N. Shoykhet, S. I. Samoylova, O. Yu. Chukhrai, S. N. Pyatakov
フォーマット:	Artigo
言語:	Inglês
出版事項:	Scientific Research Institute, Ochapovsky Regional Clinical Hospital no. 1 2023-11-01
シリーズ:	Инновационная медицина Кубани
主題:	cutaneous melanoma wide excision pdl1 level progression­free survival overall survival
オンライン･アクセス:	https://www.innovmedkub.ru/jour/article/view/764
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!